Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Bone disease in HIV infectionMaristella Francesca Saccomanno, Adriana AmmassariCurrent HIV/AIDS Reports|July 11, 2009
Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implicationsJean B Nachega, Maria Paola Trotta, Mark Nelson, et al.Antiviral Therapy|March 15, 2012
Beyond virological suppression: the role of adherence in the late HAART eraAdriana Ammassari, Maria Paola Trotta, Noga Shalev, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 26, 2017
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patientsStefania Notari, Massimo Tempestilli, Gabriele Fabbri, et al.Antiviral Therapy|June 9, 2006
Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trialAndrea De Luca, Simona Di Giambenedetto, Antonella Cingolani, et al.Journal of Clinical Microbiology|August 6, 2005
Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapyAngela Marzocchetti, Simona Di Giambenedetto, Antonella Cingolani, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 27, 2008
Oral lesions in HIV and HCV co-infected individuals in HAART eraMichele Giuliani, Carlo Lajolo, Alessandra Sartorio, et al.BMC Infectious Diseases|March 3, 2017
Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literatureGabriele Fabbri, Ilaria Mastrorosa, Alessandra Vergori, et al.Biomedical Chromatography : BMC|May 5, 2018
Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patientsMassimo Tempestilli, Adriana Ammassari, Antonio D'Avolio, et al.Infection|June 12, 2019
Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjectsAlessandra Vergori, Carmela Pinnetti, Patrizia Lorenzini, et al.Pageof 8